Erianin mitigates diabetic cardiomyopathy via adenosine monophosphate-activated protein kinase-nuclear factor erythroid 2-related factor 2-heme oxygenase-1 pathway activation

Figure 3 Indices of myocardial damage in type 2 diabetes mellitus mice. A: Creatine kinase (CK) (U/L); B: CK-isoenzymes (U/L); C: Cardiac troponin I (mg/mL). Bar charts represent the mean ± SEM, n = 8. ^cP < 0.001 vs control group; ^dP < 0.05 vs model group; ^eP < 0.01 vs model group; ^fP < 0.001 vs model group; CK: Creatine kinase; CK-MB: Creatine kinase-isoenzymes; cTnI: Cardiac troponin I.